FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Proposes PMAs for Spinal Spheres

[ Price : $8.95]

Federal Register notice: FDA proposes to require PMAs for spinal spheres for use in intervertebral fusion procedures.

Biden Bill Will Hurt Generic Drugs: Analysis

[ Price : $8.95]

A health and science policy analyst for Citizens Against Government Waste says the Build Back Better act proposed by President Bid...

Comments on ICH Q13 Continuous Manufacturing Guidance

[ Price : $8.95]

Three stakeholders submit comments and questions on a draft International Council on Harmonization guidance on continuous manufact...

AbbVie Gains Rinvoq Psoriatic Arthritis Approval

[ Price : $8.95]

FDA approves AbbVies JAK inhibitor Rinvoq (upadacitinib; 15 mg, once daily) for treating adults with active psoriatic arthritis wh...

FDA Approves BMS Orencia for Graft Versus Host Disease

[ Price : $8.95]

FDA approves a new indication for Bristol-Myers Squibbs Orencia to prevent acute graft versus host disease in combination with imm...

FDA Approves Xeljanz for Ankylosing Spondylitis

[ Price : $8.95]

FDA approves a Pfizer supplemental NDA for its JAK inhibitor Xeljanz /Xeljanz XR (tofacitinib) for treating adults with active ank...

Oncologic Panel to Review Lung Cancer Therapy

[ Price : $8.95]

Federal Register notice: FDA announces a 2/10/2022 Oncologic Drugs Advisory Committee meeting that will vote on an Innovent Biolog...

FDA Withdraws 6 No-Longer-Marketed ANDAs

[ Price : $8.95]

Federal Register notice: FDA withdraws approval of six ANDAs from multiple applicants after they notified the agency that the prod...

Info Collection on Expanded Access

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection revision entitled Expanded Access to Investigational Drug...

Pfizer Covid Oral Drug 89% Effective

[ Price : $8.95]

Pfizer says new data on its Covid-19 oral antiviral drug Paxlovid (nirmatrelvir tablets and ritonavir tablets) show the drug signi...